These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6891618)

  • 1. The structural properties and contractile force of a clot.
    Jen CJ; McIntire LV
    Cell Motil; 1982; 2(5):445-55. PubMed ID: 6891618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet microtubules in clot structure formation and contractile force generation: investigation of a controversy.
    Jen CJ; McIntire LV
    Thromb Haemost; 1986 Aug; 56(1):23-7. PubMed ID: 2877507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed, reduced or inhibited thrombin production reduces platelet contractile force and results in weaker clot formation.
    Carr ME; Martin EJ; Carr SL
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):193-7. PubMed ID: 11943932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarities between platelet contraction and cellular motility during mitosis: role of platelet microtubules in clot retraction.
    Chao FC; Shepro D; Tullis JL; Belamarich FA; Curby WA
    J Cell Sci; 1976 May; 20(3):569-88. PubMed ID: 1270531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
    Dempfle CE; Kälsch T; Elmas E; Suvajac N; Lücke T; Münch E; Borggrefe M
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):765-70. PubMed ID: 19002042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of platelet-mediated force development during plasma clot formation.
    Carr ME; Zekert SL
    Am J Med Sci; 1991 Jul; 302(1):13-8. PubMed ID: 2063881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets provide robustness of spatial blood coagulation to the variation of initial conditions.
    Balandina AN; Koltsova EM; Shibeko AM; Kuprash AD; Budkova VA; Demina IA; Ignatova AA; Fadeeva OA; Vijay R; Nair SC; Srivastava A; Shi Q; Ataullakhanov FI; Panteleev MA
    Thromb Res; 2023 Oct; 230():133-143. PubMed ID: 37717370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of recombinant factor VIIa on platelet function and clot structure in blood with deficient prothrombin conversion.
    Carr ME; Martin EJ; Kuhn JG; Seremetis SV
    Thromb Haemost; 2003 May; 89(5):803-11. PubMed ID: 12719776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of colchicine and vinblastine on platelet contractility and release.
    Kuntamukkula MS; Moake JL; McIntire LV; Cimo PL
    Thromb Res; 1982 Jun; 26(5):329-39. PubMed ID: 7164026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of platelet contractile force as a research and clinical measure of platelet function.
    Carr ME
    Cell Biochem Biophys; 2003; 38(1):55-78. PubMed ID: 12663942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents.
    Kirkpatrick JP; McIntire LV; Moake JL; Cimo PL
    Thromb Haemost; 1980 Feb; 42(5):1483-9. PubMed ID: 6892735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin structure and concentration alter clot elastic modulus but do not alter platelet mediated force development.
    Carr ME; Carr SL
    Blood Coagul Fibrinolysis; 1995 Feb; 6(1):79-86. PubMed ID: 7795157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
    Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
    Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma.
    Carr ME; Zekert SL
    Am J Physiol; 1994 Mar; 266(3 Pt 2):H1195-201. PubMed ID: 8160823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gelation kinetics of platelet extracts.
    Jen CJ; McIntire LV
    Biochim Biophys Acta; 1984 Oct; 801(3):410-5. PubMed ID: 6541506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
    Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
    Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Batroxobin-induced clots exhibit delayed and reduced platelet contractile force in some patients with clotting factor deficiencies.
    Carr ME; Carr SL; Tildon T; Fisher LM; Martin EJ
    J Thromb Haemost; 2003 Feb; 1(2):243-9. PubMed ID: 12871496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phenomenologic description of clot lysis in dilute human plasma correlating structure and function of platelets.
    Gilliam JM; Berkus V; Taylor FB
    Am J Pathol; 1979 Jul; 96(1):35-50. PubMed ID: 464023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. At high heparin concentrations, protamine concentrations which reverse heparin anticoagulant effects are insufficient to reverse heparin anti-platelet effects.
    Carr ME; Carr SL
    Thromb Res; 1994 Sep; 75(6):617-30. PubMed ID: 7831681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity.
    Kumar R; Béguin S; Hemker HC
    Thromb Haemost; 1995 Sep; 74(3):962-8. PubMed ID: 8571330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.